A mission defined by visionary science

At Biogen, we work toward new discoveries that can make a significant impact in patients’ lives and where there are few or no treatment options.

Innovations in Imaging

news
Imaging technology is enabling us to gain better insights from our clinical trials.

Core areas of focus

Our research and development efforts are primarily focused on three areas in which we are recognised leaders:

 

Neurology

The primary mission of neurology discovery at Biogen is to identify novel drug candidates for the treatment of devastating neurological and neurodegenerative diseases.

Learn more 

 

Haematology

In haematology, we are focused on exploring novel therapies for the treatment of haemophilia and further expanding our research into related areas of nonmalignant haematology, such as sickle cell disease and beta-thalassaemia.

Learn more 

 

Immunology

Immunology at Biogen is focused on exploring the immunobiology underlying autoimmune, inflammatory and fibrotic disease.

Learn more 

Gaining insight through clinical trials

Biogen conducts clinical trials to assess new treatments and to investigate potential new uses and benefits for existing therapies.

Clinical trials by Biogen

View clinical trials being conducted by Biogen

Investigators interested in research opportunities

Learn about available research programmes for investigators

Dedicated to new discoveries

Our pipeline is more than a list of medicines in development. It reflects the work we do here every day to break new ground with science that makes a difference in the lives of patients.

Science that truly matters

 

Biogen is more focused than ever on the areas where we can have the greatest impact. We built our business by putting science and patients at the centre of every decision and investment we make.

Review our 2014 performance